FDA Orange Book · active-ingredient family
Sermorelin acetate
Sermorelin acetate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:GEREF · NDA 020443
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| GEREFRLD×2 | EMD SERONO INC | NDA 020443 | — | Sep 26, 1997 | |
| GEREFRLD | EMD SERONO | NDA 019863 | — | Dec 28, 1990 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Sermorelin acetate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

